Trials / Completed
CompletedNCT02796664
Preventive Effects of Ginseng Against Atherosclerosis
Preventive Effects of Ginseng Against Atherosclerosis and Subsequent Ischemic Stroke: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Dae Chul Suh · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is a 12-month, double-blind, randomized, placebo-controlled trial. The purpose of this study is to determine whether ginseng is effective in the prevention of atherosclerosis and subsequent ischemic stroke. High-risk patients with severe atherosclerosis in the major intracranial arteries and extracranial carotid artery were enrolled.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Ginseng | Korean Red Ginseng extract tablet (0.5 grams/tablet, 2 tablets twice a day) daily for 12 months. |
| DIETARY_SUPPLEMENT | Placebo | Placebo (0.5 grams/tablet, 2 tablets twice a day) daily for 12 months. |
Timeline
- Start date
- 2016-06-23
- Primary completion
- 2018-07-04
- Completion
- 2018-07-04
- First posted
- 2016-06-13
- Last updated
- 2021-08-24
- Results posted
- 2021-08-24
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02796664. Inclusion in this directory is not an endorsement.